Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1987 Sep;69(3):550–556.

Effect of cyclosporin A on autoimmune tubulointerstitial nephritis in the brown Norway rat.

A Giménez 1, F Leyva-Cobián 1, C Fierro 1, M Río 1, T Bricio 1, F Mampaso 1
PMCID: PMC1542380  PMID: 3311496

Abstract

The effect of cyclosporin A (CyA) on the development of tubulointerstitial nephritis (TIN) in the brown Norway (BN) rat was assessed. All manifestations of TIN were prevented in rats by subcutaneously injected CyA (20 mg/kg/day). A short 7-day course of CyA beginning the day before immunization suppressed the primary and ongoing antibody response. In addition, delayed CyA treatment (starting on day 10 after immunization), when antibody response was established, drastically reduced the levels of serum anti-TBM IgG, and abrogated the interstitial inflammatory cell response, in spite of persistent kidney-bound TBM antibodies. These results indicate that CyA has a therapeutic effect on the BN rat model of TIN.

Full text

PDF
550

Images in this article

553Fig. 3
on p.553
554Fig. 4
on p.554

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bannister K. M., Wilson C. B. Transfer of tubulointerstitial nephritis in the Brown Norway rat with anti-tubular basement membrane antibody: quantitation and kinetics of binding and effect of decomplementation. J Immunol. 1985 Dec;135(6):3911–3917. [PubMed] [Google Scholar]
  2. Borel J. F., Feurer C., Magnée C., Stähelin H. Effects of the new anti-lymphocytic peptide cyclosporin A in animals. Immunology. 1977 Jun;32(6):1017–1025. [PMC free article] [PubMed] [Google Scholar]
  3. Britton S., Palacios R. Cyclosporin A--usefulness, risks and mechanism of action. Immunol Rev. 1982;65:5–22. doi: 10.1111/j.1600-065x.1982.tb00425.x. [DOI] [PubMed] [Google Scholar]
  4. Calne R. Y. Immunosuppression for organ grafting -- observations on cyclosporin A. Immunol Rev. 1979;46:113–124. doi: 10.1111/j.1600-065x.1979.tb00286.x. [DOI] [PubMed] [Google Scholar]
  5. Drachman D. B., Adams R. N., McIntosh K., Pestronk A. Treatment of experimental myasthenia gravis with cyclosporin A. Clin Immunol Immunopathol. 1985 Feb;34(2):174–188. doi: 10.1016/0090-1229(85)90022-4. [DOI] [PubMed] [Google Scholar]
  6. Gunn H. C., Ryffel B. Successful treatment of autoimmunity in (NZB X NZW)F1 mice with cyclosporin and (Nva2)-cyclosporin: II. Reduction of glomerulonephritis. Clin Exp Immunol. 1986 May;64(2):234–242. [PMC free article] [PubMed] [Google Scholar]
  7. Israel-Biet D., Noel L. H., Bach M. A., Dardenne M., Bach J. F. Marked reduction of DNA antibody production and glomerulopathy in thymulin (FTS-Zn) or cyclosporin A treated (NZB X NZW) F1 mice. Clin Exp Immunol. 1983 Nov;54(2):359–365. [PMC free article] [PubMed] [Google Scholar]
  8. Lehman D. H., Wilson C. B., Dixon F. J. Interstitial nephritis in rats immunized with heterologous tubular basement membrane. Kidney Int. 1974 Mar;5(3):187–195. doi: 10.1038/ki.1974.23. [DOI] [PubMed] [Google Scholar]
  9. Lehman D. H., Wilson C. B. Role of sensitized cells in antitubular basement membrane interstitial nephritis. Int Arch Allergy Appl Immunol. 1976;51(2):168–174. doi: 10.1159/000231589. [DOI] [PubMed] [Google Scholar]
  10. Mallamaci F., Zoccali C., Ciccarelli M., Briggs J. D. Autonomic function in uremic patients treated by hemodialysis or CAPD and in transplant patients. Clin Nephrol. 1986 Apr;25(4):175–180. [PubMed] [Google Scholar]
  11. Mampaso F. M., Wilson C. B. Characterization of inflammatory cells in autoimmune tubulointerstitial nephritis in rats. Kidney Int. 1983 Mar;23(3):448–457. doi: 10.1038/ki.1983.41. [DOI] [PubMed] [Google Scholar]
  12. Nussenblatt R. B., Palestine A. G., Chan C. C. Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents. Am J Ophthalmol. 1983 Sep;96(3):275–282. doi: 10.1016/s0002-9394(14)77814-6. [DOI] [PubMed] [Google Scholar]
  13. Palacios R. Mechanism of T cell activation: role and functional relationship of HLA-DR antigens and interleukins. Immunol Rev. 1982;63:73–110. doi: 10.1111/j.1600-065x.1982.tb00412.x. [DOI] [PubMed] [Google Scholar]
  14. Powles R. L., Clink H. M., Spence D., Morgenstern G., Watson J. G., Selby P. J., Woods M., Barrett A., Jameson B., Sloane J. Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation. Lancet. 1980 Feb 16;1(8164):327–329. doi: 10.1016/s0140-6736(80)90881-8. [DOI] [PubMed] [Google Scholar]
  15. Ryffel B., Feurer C., Heuberger B., Borel J. F. Immunosuppressive effect of cyclosporin A in two lymphocyte transfer models in rats: comparison of in vivo and in vitro treatment. Immunobiology. 1982 Dec;163(5):470–483. doi: 10.1016/S0171-2985(82)80061-2. [DOI] [PubMed] [Google Scholar]
  16. Stiller C. R., Dupré J., Gent M., Jenner M. R., Keown P. A., Laupacis A., Martell R., Rodger N. W., von Graffenried B., Wolfe B. M. Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset. Science. 1984 Mar 30;223(4643):1362–1367. doi: 10.1126/science.6367043. [DOI] [PubMed] [Google Scholar]
  17. Sugisaki T., Klassen J., Milgrom F., Andres G. A., McCluskey R. T. Immunopathologic study of an autoimmune tubular and interstitial renal disease in brown Norway rats. Lab Invest. 1973 Jun;28(6):658–671. [PubMed] [Google Scholar]
  18. Thomson A. W., Moon D. K., Nelson D. S. Suppression of delayed-type hypersensitivity reactions and lymphokine production by cyclosporin A in the mouse. Clin Exp Immunol. 1983 Jun;52(3):599–606. [PMC free article] [PubMed] [Google Scholar]
  19. Tipping P. G., Holdsworth S. R. Effect of cyclosporin A on antibody-induced experimental glomerulonephritis. Nephron. 1985;40(2):201–205. doi: 10.1159/000190341. [DOI] [PubMed] [Google Scholar]
  20. Zanetti M., Mampaso F., Wilson C. B. Anti-idiotype as a probe in the analysis of autoimmune tubulointerstitial nephritis in the Brown Norway rat. J Immunol. 1983 Sep;131(3):1268–1273. [PubMed] [Google Scholar]
  21. Zanetti M., Wilson C. B. Characterization of anti-tubular basement membrane antibodies in rats. J Immunol. 1983 May;130(5):2173–2179. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES